GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VentriPoint Diagnostics Ltd (TSXV:VPT) » Definitions » Equity-to-Asset

VentriPoint Diagnostics (TSXV:VPT) Equity-to-Asset : 0.10 (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is VentriPoint Diagnostics Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. VentriPoint Diagnostics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was C$0.19 Mil. VentriPoint Diagnostics's Total Assets for the quarter that ended in Dec. 2023 was C$1.88 Mil. Therefore, VentriPoint Diagnostics's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.10.

The historical rank and industry rank for VentriPoint Diagnostics's Equity-to-Asset or its related term are showing as below:

TSXV:VPT' s Equity-to-Asset Range Over the Past 10 Years
Min: -7.86   Med: -1.52   Max: 0.87
Current: 0.1

During the past 13 years, the highest Equity to Asset Ratio of VentriPoint Diagnostics was 0.87. The lowest was -7.86. And the median was -1.52.

TSXV:VPT's Equity-to-Asset is ranked worse than
90.45% of 869 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs TSXV:VPT: 0.10

VentriPoint Diagnostics Equity-to-Asset Historical Data

The historical data trend for VentriPoint Diagnostics's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VentriPoint Diagnostics Equity-to-Asset Chart

VentriPoint Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.86 -2.93 0.87 0.76 0.10

VentriPoint Diagnostics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.76 0.70 0.62 0.45 0.10

Competitive Comparison of VentriPoint Diagnostics's Equity-to-Asset

For the Medical Devices subindustry, VentriPoint Diagnostics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VentriPoint Diagnostics's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where VentriPoint Diagnostics's Equity-to-Asset falls into.



VentriPoint Diagnostics Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

VentriPoint Diagnostics's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=0.19/1.883
=0.10

VentriPoint Diagnostics's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=0.19/1.883
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


VentriPoint Diagnostics  (TSXV:VPT) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


VentriPoint Diagnostics Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of VentriPoint Diagnostics's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


VentriPoint Diagnostics (TSXV:VPT) Business Description

Traded in Other Exchanges
Address
18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.
Executives
Robert Hodgkinson Director

VentriPoint Diagnostics (TSXV:VPT) Headlines

No Headlines